Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #6389
Reference
Drug alert 16/2018
Name
Drug alert class 2 no 16 2018: action within 48 hours [Allergan Pharmaceuticals Ireland - Ozurdex 700 micrograms intravitreal implant in applicator]
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
Description
Allergan Pharmaceuticals Ireland is recalling the seventeen batches due to the possibility that a single loose silicone particle of approximately 300microns in diameter may become detached from the needle sleeve during administration of the implant and may be delivered into the eye along with the implant.
Contact Name
Irene Fazakerley
Contact Email
Contact Address
St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2018-10-05 00:00:00
Click to go back to homepage